Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
26°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anika Therapeutics Inc. - Common Stock
(NQ:
ANIK
)
14.51
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anika Therapeutics Inc. - Common Stock
< Previous
1
2
3
Next >
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
April 25, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday
March 13, 2025
Via
Benzinga
What's Next: Anika Therapeutics's Earnings Preview
October 30, 2024
Via
Benzinga
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
March 13, 2025
U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
March 13, 2025
Via
Benzinga
Anika Completes Divestiture of Parcus Medical
March 07, 2025
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Earnings Scheduled For March 12, 2025
March 12, 2025
Via
Benzinga
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 25, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
May 29, 2024
Via
Benzinga
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
